TY - JOUR
T1 - Memory matters in dementia
T2 - Efficacy of a mobile reminiscing therapy app
AU - Yu, Fang
AU - Mathiason, Michelle A.
AU - Johnson, Kari
AU - Gaugler, Joseph E.
AU - Klassen, Dan
N1 - Funding Information:
The research study reported in this publication was supported by the Small Business Innovation Research grant from the National Institute on Aging of the National Institutes of Health that was awarded to Moai Technologies, LLC (Award #: 9R44AG053923-02). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Authors' contributions: F.Y. designed and implemented the study, analyzed data, and drafted the manuscript. M.A.M. cleaned and analyzed data and drafted the manuscript. J.E.G. designed the study and drafted the manuscript. K.J. implemented the study, collected data, and drafted the manuscript. D.K. designed the study, analyzed data, and drafted the manuscript.
Publisher Copyright:
© 2019 The Authors
PY - 2019
Y1 - 2019
N2 - Introduction: Reminiscence therapy has been shown to improve mental health and quality of life in dementia; however, reminiscence therapy is often delivered by therapists instead of being technology-enabled. This study evaluated the preliminary efficacy of Memory Matters (MM), an iPad reminiscence game on mood, social interaction, quality of life, and behavioral and psychological symptoms of dementia. Methods: This pilot study used an experimental design where participants were randomized on a 2:2:1 ratio to three arms: individual MM (one-on-one with an interventionist), group MM (2–3 participants per session), or waitlist control. MM was delivered for 30 minutes a session, twice a week for six weeks, followed by six-week self-play. Outcomes were assessed at the baseline, six weeks, and 12 weeks by data collectors blinded to group allocation. Data were analyzed using intention-to-treat analysis and analysis of covariance. Results: The sample (n = 80) was 82.1 ± 7.8 years in age with 58% female, 15.3 ± 3.3 years of education. Mood did not differ, except for apathetic mood between group MM and control arm at 12 weeks (P = .051). Social interaction improved for individual MM compared with group MM (t = 2.38, P = .017) and control (t = 2.84, P = .005) at six weeks, but not 12 weeks. Other outcomes did not differ. Discussion: MM improved social interaction and possibly mood. Future studies are needed to evaluate the efficacy of MM with a sufficient sample size.
AB - Introduction: Reminiscence therapy has been shown to improve mental health and quality of life in dementia; however, reminiscence therapy is often delivered by therapists instead of being technology-enabled. This study evaluated the preliminary efficacy of Memory Matters (MM), an iPad reminiscence game on mood, social interaction, quality of life, and behavioral and psychological symptoms of dementia. Methods: This pilot study used an experimental design where participants were randomized on a 2:2:1 ratio to three arms: individual MM (one-on-one with an interventionist), group MM (2–3 participants per session), or waitlist control. MM was delivered for 30 minutes a session, twice a week for six weeks, followed by six-week self-play. Outcomes were assessed at the baseline, six weeks, and 12 weeks by data collectors blinded to group allocation. Data were analyzed using intention-to-treat analysis and analysis of covariance. Results: The sample (n = 80) was 82.1 ± 7.8 years in age with 58% female, 15.3 ± 3.3 years of education. Mood did not differ, except for apathetic mood between group MM and control arm at 12 weeks (P = .051). Social interaction improved for individual MM compared with group MM (t = 2.38, P = .017) and control (t = 2.84, P = .005) at six weeks, but not 12 weeks. Other outcomes did not differ. Discussion: MM improved social interaction and possibly mood. Future studies are needed to evaluate the efficacy of MM with a sufficient sample size.
KW - Dementia
KW - Mood
KW - Quality of life
KW - Reminiscence
KW - Social interaction
UR - http://www.scopus.com/inward/record.url?scp=85073690328&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073690328&partnerID=8YFLogxK
U2 - 10.1016/j.trci.2019.09.002
DO - 10.1016/j.trci.2019.09.002
M3 - Article
AN - SCOPUS:85073690328
VL - 5
SP - 644
EP - 651
JO - Alzheimer's and Dementia: Translational Research and Clinical Interventions
JF - Alzheimer's and Dementia: Translational Research and Clinical Interventions
SN - 2352-8737
ER -